Downregulation of DNMT3B by miR-145 was achieved through direct targeting, and DNMT3B knockdown increased expression of miR-145 by CpG island promoter hypomethylation, consequently sensitizing prostate cancer cells to radiation [74]. Here, DNMT3B is linked to prostate carcinoma.